Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome

Psychosomatic Medicine

Volumn 68, Issue 4, 2006, Pages 578-582

  Jerjes, Walid K ^a,c   Taylor, Norman F ^a   Peters, Timothy J ^a   Wessely, Simon ^b   Cleare, Anthony J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Cortisol metabolite ratios; Cortisol metabolites; Excretion; Hypoadrenalism; Sex differences

Indexed keywords

ALLOTETRAHYDROCORTISOL; HYDROCORTISONE; TETRAHYDROCORTISOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CALCULATION; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEDICAL PARAMETERS; METABOLITE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; URINARY EXCRETION; VARIANCE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; BODY MASS INDEX; CIRCADIAN RHYTHM; CONTROL GROUPS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; METABOLIC CLEARANCE RATE; PITUITARY-ADRENAL SYSTEM; PREGNANES; SEX FACTORS; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

EID: 33748079481     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000222358.01096.54     Document Type: Article

References (50)

1. Starkman MN, Schteingart DE, Schork MA. Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 1981;431:3-18.
2. Demitrack MA, Dale JK, Straus S, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW. Evidence for impaired activation of hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-34.
3. Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995;35:283-9.
4. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneurorendocrine research: recent developments and applications. Psychoneuroendocrinology 1994;19:313-33.
5. Wade SE, Haegele AD. Time-integrated measurement of corticosteroids in saliva by oral diffusion sink technology. Clin Chem 1991;37:1166-72.
6. Strickland P, Morriss R, Wearden A, Deakin W. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 1998;47:191-4.
7. Roberts ADL, Wessely S. Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 2004;184:136-41.
8. Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J Affect Disord 2005;87:299-304.
9. Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. Biol Psychiatry 1998;43:236-7.
10. Gaab J, Huster D, Peisen R, Engert V, Schad T, Schurmeyer TH, Ehlert U. The low dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 2002;64:311-8.
11. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003;24:236-52.
12. Thompson LM, Rubin RT, McCracken JT. Neuroendocrine aspects of primary endogenous depression. 12. Receiver operating characteristics and kappa analysis of serum and urine cortisol measure in patients and matched controls. Psychoneuroendocrinology 1992;17:507-15.
13. Murphy BEP. Urinary free cortisol determinations: what they measure. Endocrinologist 2002;12:143-50.
14. Raven PW, Taylor NF. Sex differences in the human metabolism of cortisol. Endocr Res 1996;22:751-5.
15. Fink RS, Pierre LN, Daley-Yates PT, Richards DH, Gibson A, Honour JW. Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation. J Clin Endocrinol Metab 2002;87:4541-6.
16. Raven PW, Taylor NF. 11β-HSD and 17 β-HSD as biological markers of depression: sex differences and correlation with symptom severity. Endocr Res 1998;24:659-62.
17. Makin HLJ. Biochemistry of Steroid Hormones, 2nd ed. New York: Oxford; 1984:349-51.
18. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komeroff A. The chronic fatigue syndrome. Ann Intern Med 1994;121:953-9.
19. Sharpe M, Chalder T, Palmer I, Wessely S. Chronic fatigue syndrome. A practical guide to assessment and management. Gen Hosp Psychiatry 1997;19:185-99.
20. Chalder T, Berelowitz G, Pawlikowska T, Watta L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
21. Moore A, Aitken R, Burke C, Gaskell S, Groom G, Holder G, Selby C, Wood P. Cortisol assays: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem 1985;22:435-54.
22. Raven PW, Checkley SA, Taylor NF. Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11β-hydroxysteroid dehydrogenase: a model for 11-HSD I deficiency. Clin Endocrinol 1995;43:637-44.
23. Scott L, Dinan T. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998;47:49-54.
24. Cleare AJ, Blair D, Chambers S, Wessely S. Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry 2001;158:641-3.
25. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. Hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome and the effects of low dose hydrocortisone therapy. J Clin Endocrinol Metab 2001;86:3545-54.
26. Hamilos DL, Nutter D, Gershtenson J, Redmond DP, Clementi JD, Schmaling KB, Make BJ, Jones JF. Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatry 1998;43:293-302.
27. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993;77:341-6.
28. Baison-Lauber A, Suter SL, Shackleton CH, Zachman M. Apparent cortisone reductase deficiency: a rare cause of hyperandrogenaemia and hypercortisolism. Hormone Res 2000;53:260-6.
29. Rodin DA, Thakkar H, Taylor NF, Clayton RN. Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 1993;330:460-5.
30. Chin D, Shackleton C, Prasad VK, Kohn B, David R, Imperato-McGinley J, Cohen H, McMahon DJ, Oberfield SE. Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Paediatr Endocrinol Metab 2000;13:253-9.
31. Cleare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 2004;15:55-9.
32. Scott LV, Medbank S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998;97:450-7.
33. Scott LV, Burnett F, Medbank S, Dinan TG. Nalocone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998;28:285-93.
34. Gaab J, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U. Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 2004;56:419-24.
35. MacHale SM, Cavanagh JT, Bennie J, Carroll S, Goodwin GM, Lawrie SM. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998;38:213-7.
36. Racciatti D, Sensi S, De Remigis P, Barberio A, Di Sciascio T, Pizzigallo E. Neuroendocrine aspects of chronic fatigue syndrome. Am J Med 1998;104:1S-3S.
37. Ricketts ML, Shoesmith KJ, Hewison, M, Strain A, Eggo MC, Stewart PM. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rats and human hepatocytes. J Endocrinol 1998;156:159-68.
38. White PC, Mune T, Agarwal AK. 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralcorticoid excess. Endocr Rev 1997;18:135-56.
39. Poor V, Juricskay S, Gati A, Osvath P, Tenyi T. Urinary steroid metabolites and 11β-hydroxysteroid dehydrogenase activity in patients with unipolar recurrent major depression. J Affect Disord 2004;81:55-9.
40. Raven PW, Taylor NF. Evidence for independent modulation of human 11-HSD and 5α/5β reductase activities. Endocr Res 1996;22:811-5.
41. Raven PW, Taylor NF. Dissociation of human 11-HSD and 5α/5β reductase activities. J Endocrinol 1997;152(suppl):abstract P275.
42. Lamb EJ, Noonan KA, Burrin JM. Urine-free cortisol excretion: evidence of sex-dependence. Ann Clin Biochem 1994;31:455-8.
43. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996;45:605-11.
44. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garacia-Borreguero D, Blackwelder W, Straus SE. Low dosed hydrocortisone for treatment of chronic fatigue syndrome. JAMA 1998;280:1061-6.
45. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999;353:455-8.
46. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A, Haugland JM, Lambrecht LJ, Swan S, Goldsmith S. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998;158:908-14.
47. Rowe PC, Calkins H, De Busk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001;285:52-9.
48. Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomised, placebo-controlled, double-blind, crossover study. Am J Med 2003;114:736-41.
49. Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and Its Syndromes. Oxford: Oxford University Press; 1998.
50. Wells JE, Horwood LJ. How accurate is recall of key symptoms of depression? A comparison of recall and longitudinal reports. Psychol Med 2004;34:1001-11.